Guidance

COVID-19: rapid tests for use in community pharmacies or at home

Advice on the use of rapid point of care tests for COVID-19.

This publication was withdrawn on

This guidance has been superseded by information available at: COVID-19: rapid point of care (near-person) testing for service providers

Documents

Details

Some manufacturers are selling products for the diagnosis of COVID-19 infection in community settings, such as pharmacies. The current view by PHE is that use of these products is not advised.

Updates to this page

Published 15 March 2020
Last updated 11 May 2020 + show all updates
  1. Clarification that these are rapid point of care tests, different from those offered as part of testing for essential workers.

  2. First published.

Sign up for emails or print this page